Mephenoxalone: Difference between revisions
Appearance
Content deleted Content added
+ Legal status in Brazil |
|||
(22 intermediate revisions by 18 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Muscle relaxant}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| IUPAC_name = 5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one |
| IUPAC_name = 5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one |
||
| image = Mephenoxalone.svg |
| image = Mephenoxalone.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = Dorsiflex, Moderamin, Control-OM |
||
| Drugs.com = {{drugs.com|international|mephenoxalone}} |
| Drugs.com = {{drugs.com|international|mephenoxalone}} |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|||
| legal_BR = C1 |
|||
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-04-04}}</ref> |
|||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|||
| legal_DE = <!-- Anlage I, II, III or Unscheduled --> |
|||
| legal_NZ = <!-- Class A, B, C --> |
|||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|||
| legal_EU = |
|||
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV --> |
|||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
Line 15: | Line 28: | ||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 70-07-5 |
| CAS_number = 70-07-5 |
||
| ATC_prefix = N05 |
| ATC_prefix = N05 |
||
| ATC_suffix = BX01 |
| ATC_suffix = BX01 |
||
| PubChem = 6257 |
| PubChem = 6257 |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 2104790 |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = CZ87T54W8W |
| UNII = CZ87T54W8W |
||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D07318 |
| KEGG = D07318 |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 6021 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=11 | H=13 | N=1 | O=4 |
| C=11 | H=13 | N=1 | O=4 |
||
| smiles = O=C2OC(COc1c(OC)cccc1)CN2 |
|||
| molecular_weight = 223.225 g/mol |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C11H13NO4/c1-14-9-4-2-3-5-10(9)15-7-8-6-12-11(13)16-8/h2-5,8H,6-7H2,1H3,(H,12,13) |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = ZMNSRFNUONFLSP-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Mephenoxalone''' ('''Dorsiflex''', '''Moderamin''' |
'''Mephenoxalone''' (trade names '''Dorsiflex''', '''Moderamin''', '''Control-OM''') is a [[muscle relaxant]]<ref>{{cite journal | vauthors = Magnenat M | title = [The utilization in psychotherapy of a tensiolytic agent with muscle relaxant effect, Control OM (mephenoxalone), alone or associated with thymoleptics] | journal = Therapeutische Umschau. Revue Therapeutique | volume = 18 | pages = 516–20 | date = December 1961 | pmid = 14468333 }}</ref> and mild [[anxiolytic]].<ref>[[Monthly Index of Medical Specialities|MIMS]]: [http://www.mims.com/USA/drug/info/mephenoxalone/ Mephenoxalone]</ref> It inhibits neuron transmission, relaxing skeletal muscles by inhibiting the [[reflex arc]].{{citation needed|date=December 2013}} As the effect of muscle relaxation, mephenoxalone affects mental condition, and is also a treatment for nervousness and [[anxiety]]. |
||
== See also == |
|||
* [[Chlorphenesin]] |
|||
* [[Guaifenesin]] |
|||
* [[Mephenesin]] |
|||
* [[Metaxalone]] |
|||
* [[Methocarbamol]] |
|||
== References == |
== References == |
||
{{Reflist |
{{Reflist}} |
||
{{Unreferenced|date=March 2010}} |
|||
{{Anxiolytics}} |
{{Anxiolytics}} |
||
{{Muscle relaxants}} |
{{Muscle relaxants}} |
||
{{Sedatives}} |
|||
[[Category:Carbamates]] |
[[Category:Carbamates]] |
||
[[Category:Drugs with unknown mechanisms of action]] |
|||
[[Category:Oxazolidines]] |
[[Category:Oxazolidines]] |
||
[[Category:Phenol ethers]] |
[[Category:Phenol ethers]] |
||
[[Category:Methoxy compounds]] |
|||
{{musculoskeletal-drug-stub}} |
{{musculoskeletal-drug-stub}} |
||
{{ |
{{sedative-stub}} |
Latest revision as of 07:58, 16 August 2023
Clinical data | |
---|---|
Trade names | Dorsiflex, Moderamin, Control-OM |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.658 |
Chemical and physical data | |
Formula | C11H13NO4 |
Molar mass | 223.228 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Mephenoxalone (trade names Dorsiflex, Moderamin, Control-OM) is a muscle relaxant[2] and mild anxiolytic.[3] It inhibits neuron transmission, relaxing skeletal muscles by inhibiting the reflex arc.[citation needed] As the effect of muscle relaxation, mephenoxalone affects mental condition, and is also a treatment for nervousness and anxiety.
See also
[edit]References
[edit]- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ Magnenat M (December 1961). "[The utilization in psychotherapy of a tensiolytic agent with muscle relaxant effect, Control OM (mephenoxalone), alone or associated with thymoleptics]". Therapeutische Umschau. Revue Therapeutique. 18: 516–20. PMID 14468333.
- ^ MIMS: Mephenoxalone